Date of Conferral







Michael Plasay


Hypogonadism negatively impacts various psychological aspects of a male’s life. Males under the age of 50 who experience symptoms of depression or a decreased sense of well-being may not be aware that secondary hypogonadism might be the underlying cause. A gap exists in the literature regarding the psychological effects of testosterone replacement therapy used to treat hypogonadism. The current research project was framed by Engel’s biopsychosocial theory, which encompasses the biological, psychological, and social aspects of a client’s life. The research objective was to determine the relationship between testosterone replacement therapy and the psychological effects of depression and quality of life amongst males under the age of 50 who have been diagnosed with secondary hypogonadism. Secondary data were gathered on 17 males with the assistance of a health clinic on the East Coast of the United States. Statistically significant differences were found in the reported levels of depression and quality of life. This study provides additional guidance to clinical psychologists, primary-care physicians, psychiatrists, pediatricians, endocrinologists, and internal medicine specialists who see males under the age 50 in their practice settings. The results of this study could influence positive social change by increasing awareness of a medical issue that can mimic symptoms of depression and anxiety.